Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 8.70M | $ 9.20M | $ 6.90M | $ 6.90M | $ 4.60M |
Total Assets | $ 33.90M | $ 36.80M | $ 28.20M | $ 35.60M | $ 46.10M |
Total Debt | $ 20.30M | $ 20.20M | $ 20.20M | $ 20.40M | $ 42.40M |
Net Debt | $ 11.60M | $ 11.00M | $ 13.30M | $ 13.50M | $ 37.80M |
Total Liabilities | $ 32.70M | $ 35.30M | $ 65.40M | $ 78.60M | $ 109.00M |
Stockholders Equity | $ 1.20M | $ 1.50M | $ -37.20M | $ -43.00M | $ -62.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |